Logo for Aspect Biosystems

Meet an Unreasonable Venture

Aspect Biosystems

Creating functional human tissues on demand via 3D bio-printing and tissue engineering.

Photo of Tamer Mohamed

Tamer Mohamed

Founder and CEO at Aspect Biosystems

More about Tamer »
Employees 21–50
Headquarters Vancouver, British Columbia, Canada
Aspect Biosystems is a biotechnology company creating bioprinted tissue therapeutics to transform how we treat disease. Aspect is combining its proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design to create a pipeline of allogeneic tissues that replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.

Currently Operating in Nine Regions

Press Mentions

August 3, 2022

Bloomberg New Economy Announces 2022 Class of Catalysts

Read on Bloomberg.com »

November 15, 2022

Tamer Mohamed, CEO of Aspect Biosystems, is turning sci-fi into reality

Read on YouTube »

July 21, 2020

The B.C. engineer behind 3D-printed human tissues

Read on Business in Vancouver »

January 9, 2020

Aspect Biosystems Raises US$20M in Series A Financing

Read on FinSMEs »

June 5, 2019

Aspect Biosystems Partners with Merck, GSK, and McGill University to Enable Development of Immuno-Oncology Therapeutics

Read more »

Work at Aspect Biosystems

Posted March 4, 2023

Research Associate, In vivo

Vancouver, BC, Canada

View Listing »

Posted February 24, 2023

People & Culture Manager

Vancouver, BC, Canada

View Listing »

Posted December 15, 2022

Laboratory and Facilities Manager

Vancouver, BC, Canada

View Listing »

More Ventures in Health

Get the Unreasonable Newsletter

Get twice-monthly updates on Aspect Biosystems and over 361 other ventures working to solve the world's toughest problems.

Read our Privacy Policy.